数字农科院2.0

mRNA-lipid nanoparticle vaccines provide protection against lethal Nipah virus infection

文献类型： 外文期刊

作者： Tong Sun;Yanfeng Yao;Chuanwen Tian;Yun Peng;Yingnan Liu;Ge Gao;Zhisheng Li;Hang Liu;Jingyi Han;Miaoyu Chen;Shuqi Xiao;Zhiming Yuan;Chao Shan;Jingyi Liu;Hongjun Chen

作者机构：

期刊名称： npj Vaccines

ISSN：

年卷期： 2025 年 11 卷 1 期

页码：

收录情况： SCIE（2025版）

摘要： Nipah virus (NiV) is a zoonotic pathogen that causes severe encephalitis and respiratory disease in humans and multiple mammalian species. However, no licensed vaccines or therapeutics are currently available against NiV infection. In this study, we developed three mRNA vaccine candidates using a lipid nanoparticle (LNP) delivery platform: mRNA-F-LNP, comprising mRNA encoding the fusion protein (F); mRNA-G-LNP, containing mRNA encoding the attachment glycoprotein (G); and mRNA-GF-LNP, in which mRNAs encoding both F and G proteins were co-encapsulated at a 1:1 molar ratio. All three mRNA-LNPs induced robust and sustained immune responses in both mice and Syrian hamsters. Sera from immunized Syrian hamster showed high levels of cross-neutralizing antibodies against both NiV-Malaysia (NiV-M) and NiV-Bangladesh (NiV-B) strains. Notably, all three mRNA-LNPs conferred complete protection against a lethal challenge with NiV-M in Syrian hamsters. These findings demonstrate that these mRNA-based vaccines are highly immunogenic and efficacious, highlighting their potential as promising candidates for NiV vaccine development.

分类号：

  • 相关文献
作者其他论文 更多>>